Fusion Pharmaceuticals Inc. Deferred Tax Liabilities, Other

Fusion Pharmaceuticals Inc. Deferred Tax Liabilities, Other

Fusion Pharmaceuticals Inc. had Deferred Tax Liabilities, Other of $209.00 thousand as of 2020-12-31, per its 10-K filed 2022-03-17.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net

us-gaap:DeferredTaxLiabilitiesOther · last filed 2022-03-17

• 2020-12-31: Deferred Tax Liabilities, Other $209.00K.